ARCHIVES

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

Waksal Pleads Guilty To Securities Fraud

October 18, 2002

Concept Approved For New Quality Assurance Center

May 14, 1982

House Democrats Take More Swings At Tobacco Industry

February 17, 1989

NCI To Support 39 Summer Students With Gift Money

February 8, 1985

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013